Endocrinology and Diabetes Update for the Primary Care Provider – Spring 2020
Present clinicians with current and emerging strategies in the management of patients with diabetes mellitus including the role sodium-glucose transport 2 inhibitors (SGLT-2i) and glucagon-like peptide-1 (GLP-1) agonists, the impact of these agents on the risk of cardiovascular and diabetic kidney disease, and effective utilization of continuous glucose monitoring to guide clinical decision-making in a primary care office.
The Mansion on Main Street
|Tuesday, Apr. 21, 2020 5:30 pm - 8:00 pm||$0 - $25||Register Now|